DENVER, March 08, 2017 -- Hemp Oil Liposomes in Citrus Twist flavor, by global cannabidiol (CBD) hemp oil producer, Elixinol, has received the “Best tasting CBD Tincture” award for its robust and pleasant citrus flavor in the 3rd annual “Best of Edibles” awards presented by Edibles List Magazine. The Edibles List Magazine award ceremony took place on February 26, 2017 in Los Angeles. Over 30 other edible category winners were also announced.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/cd09e760-7a52-4382-b6e6-16e1abd19b76.
“We really have our customers to thank for this award,” said Chris Husong, Elixinol’s Marketing Director.
“We developed Hemp Oil Liposomes with real citrus flavor because of customer feedback about the taste of CBD tinctures, this award combined with 300% increase in product sales is confirmation that we’ve succeeded,” Husong continued.
In addition to refreshing citrus taste, Hemp Oil Liposomes also use a water-based liposome which increases the bioavailability of the organic CBD hemp oil, enabling customers to use less and see more benefits from each serving.
A complete list of Edible Awards winners is located: http://ediblesmagazine.com/edibles/winners-announced/
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico and the UK. More information available at Elixinol.com.
Media Contact: Chris Husong Elixinol +1 844-804-3504 ext 420 [email protected]


Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Instagram Outage Disrupts Thousands of U.S. Users
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



